Nasdaq:US$14.79 (+0.91) | HKEX:HK$22.35 (+0.90) | AIM:£2.41 (+0.21)
Sustainability

2021 Sustainability Report

About This Report

This Report gives an annual update of HUTCHMED’s sustainability performance during 2021, including a comprehensive account of HUTCHMED's sustainability manage­ment approaches over topics identified as material to HUTCHMED's business and stakeholders relating to the operations of the two segments: (1) Oncology/­Immunology and (2) Other Ventures.

Details of our corporate governance principles are contained in the Corporate Governance Report within our 2021 Annual Report.

Reporting Framework: This Report has been prepared in accordance with the provisions of the ESG Reporting Guide (Main Board Listing Rules Appendix 27) (“ESG Guide”) issued by The Stock Exchange of Hong Kong Limited (“HKEX”), and with reference to the Nasdaq ESG Reporting Guide, the London Stock Exchange Group's ESG Reporting Guidance, as well as mapped against the United Nations Sustainable Development Goals (“SDGs”).

HUTCHMED’s Material Topics

  • Business ethics, including staff and partner awareness

  • Drug research-related topics, including animal welfare and intellectual property

  • Drug development-related topics, including clinical trial safety and personal data privacy and security

  • Commercial operations responsibilities, including quality, safety and traceability; patient monitoring and reporting; responsible marketing; and fair access of drugs

  • Environmental topics including waste and emissions

  • Management of our people, including talent acquisition, retention, development and engagement; occupational health and safety; and community investment.

Sustainability-related Policies

With reference to local and international guidelines and standards on sustainability, we have formulated a series of sustainability and governance policies and statements. Details of each policy can be found here.

Key Environmental Data 2021

  Unit Oncology/​Immunology & Hutchison Sinopharm (consolidated entities) SHPL
(non-consolidated joint venture)
Combined Total
Revenue Note 1 US$'000 334,388 332,648 667,036
Employee person 1,715 2,883 4,598
GHG emissions (tCO₂e)
Total Emissions tCO₂e 7,029 14,476 21,505
Direct GHG emissions (Scope 1) tCO₂e 313 4,856 5,169
Indirect GHG emissions (Scope 2) tCO₂e 6,716 9,620 16,336
Total GHG emission intensity (Scope 1 & 2) Note 1 tCO₂e per US$ ’000 revenue 0.021 0.044 0.032
tCO₂e per employee 4.10 5.02 4.68
Air emissions
Nitrogen Oxides (NOx) kg 5.38 879 884
Sulphur Oxides (SOx) Kg 0.12 0.33 0.45
Particulate Matter (PM) Kg 0.40 155 155
Total energy Consumption
Total Energy Consumption GJ 41,439 184,110 225,549
Electricity Consumption GJ 41,140 58,743 99,883
Steam consumption GJ 11 0 11
Natural gas consumption GJ 0 124,587 124,587
Diesel consumption GJ 0 2 2
Gasoline consumption GJ 288 779 1,067
Total energy intensity Note 1 GJ/US$'000 revenue 0.124 0.553 0.338

tCO₂e = tonnes (metric tons, t) of carbon dioxide (CO₂) equivalent (e). GJ = Giga Joule (GJ), which is equal to 1 x 10⁹ joule (J).
Note 1: Revised on June 15, 2022 owing to revised segment revenue figures.

 

GHG emissions (Combined)

GHG emissions (tCO2e) 2021 2020 Change (%)
Total emissions (tCO2e) 21,505 21,946 -2%
Direct GHG emission (Scope 1) 5,169 6,040 -14%
Indirect GHG emission (Scope 2) 16,336 15,906 3%
Total GHG emission intensity (tCO2e)/ US$'000 revenue Note 1 0.032 0.046 -30%
Total GHG emission intensity (tCO2e) / employee 4.68 5.30 -12%

tCO₂e = tonnes (metric tons, t) of carbon dioxide (CO₂) equivalent (e)
Note 1: Revised on June 15, 2022 owing to revised segment revenue figures.

Sustainable Development Goals

Our actions support the following United Nations Sustainable Development Goals:

Previous Reports